Advanced search
Start date
Betweenand

Policies to increase the competitiveness of the pharmaceutical sector: Brazil's experience

Grant number: 15/18604-5
Support type:Research Grants - Young Investigators Grants
Duration: December 01, 2016 - November 30, 2020
Field of knowledge:Applied Social Sciences - Administration
Principal Investigator:Elize Massard da Fonseca
Grantee:Elize Massard da Fonseca
Home Institution: Escola de Administração de Empresas (EAESP). Fundação Getúlio Vargas (FGV). São Paulo, SP, Brazil
Assoc. researchers: Catarina Ianni Segatto ; Francisco Inacio Pinkusfeld Monteiro Bastos
Associated grant(s):17/50120-3 - Promoting and regulating generic medicines in Latin America, AP.R
Associated scholarship(s):19/00603-3 - Understanding the political activity of companies from the health care sector in Brazil, BP.TT
18/17907-2 - Political economy of pharmaceutical regulation in Latin America, BP.IC
18/19737-7 - Political economy of generic drug regulation in Latin America, BP.IC
+ associated scholarships 18/02686-0 - Health industrial policy in comparative perspective, BP.IC
17/05554-5 - New frontiers in research and development of medicines: the experience of public-private partnerships in the pharmaceutical sector, BP.IC
17/04076-2 - Data survey on the health-industry complex in Brazil, BP.IC
16/24282-3 - Policies to increase the competitiveness of the pharmaceutical sector: an analysis in comparative perspective of Brazil's experience, BP.JP - associated scholarships

Abstract

The Brazilian government has invested in its pharmaceutical sector as part of an innovative strategy for economic and technological development. In parallel, it increased access to high-cost medicines such as drugs to treat cancer or AIDS through the National Health System. Social science scholars have paid relatively little attention to these initiatives, focusing instead on the impact of the health-industry complex (CIS) on economic development. As such, little is known about the political processes underlying this public policy innovation. The present research will analyze (i) why and how Brazil selected to implement policies to stimulate the competitiveness of its pharmaceutical sector; (ii) the contribution of civil society and the private sector to the development of policies for CIS and pharmaceutical regulation are also explored. This qualitative study combines formal and informal documentary sources with in-depth interviews to assess the political actions of key stakeholders in the health sector. This analysis contributes to the understanding of the process of development of these policies and of the dynamics of interest groups in influencing regulation, which is understudied in the literature. Hopefully, this research will stimulate scholars to further investigate the pharmaceutical sector in Brazil, yet little explored in comparison to other segments of the economy. (AU)

Articles published in Agência FAPESP about the research grant
Study analyzes regulation of generic drugs in Brazil 

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DA FONSECA, ELIZE MASSARD; BASTOS, FRANCISCO INACIO. Evolution of HIV/AIDS response in Brazil: Policy innovations and challenges in the fourth decade of the epidemic. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, v. 33, n. 1, p. E238-E250, JAN-MAR 2018. Web of Science Citations: 0.
DA FONSECA, ELIZE MASSARD. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil. GLOBAL PUBLIC HEALTH, v. 13, n. 4, p. 489-502, 2018. Web of Science Citations: 3.
DA FONSECA, ELIZE MASSARD; SHADLEN, KENNETH C. Promoting and regulating generic medicines: Brazil in comparative perspective. Revista Panamericana de Salud Pública = Pan American Journal of Public Health, v. 41, 2017. Web of Science Citations: 1.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.